Treatment in metastatic melanoma-time to re-think

Ann Oncol. 2019 Apr 1;30(4):501-503. doi: 10.1093/annonc/mdz050.

Authors

D Schadendorf¹, E Livingstone², L Zimmer²

Affiliations

¹ Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Heidelberg, Germany. Electronic address: [email protected].
² Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Heidelberg, Germany.

PMID: 30768148
DOI: 10.1093/annonc/mdz050

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Humans
Melanoma*
Patients
Time

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab